DE2311099A1 - Psychopharmakologisch aktive peptide und peptidderivate - Google Patents

Psychopharmakologisch aktive peptide und peptidderivate

Info

Publication number
DE2311099A1
DE2311099A1 DE19732311099 DE2311099A DE2311099A1 DE 2311099 A1 DE2311099 A1 DE 2311099A1 DE 19732311099 DE19732311099 DE 19732311099 DE 2311099 A DE2311099 A DE 2311099A DE 2311099 A1 DE2311099 A1 DE 2311099A1
Authority
DE
Germany
Prior art keywords
phe
met
group
peptide
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732311099
Other languages
German (de)
English (en)
Inventor
Hendrik Marie Greven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of DE2311099A1 publication Critical patent/DE2311099A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19732311099 1972-03-08 1973-03-06 Psychopharmakologisch aktive peptide und peptidderivate Pending DE2311099A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7203042A NL7203042A (fr) 1972-03-08 1972-03-08

Publications (1)

Publication Number Publication Date
DE2311099A1 true DE2311099A1 (de) 1973-09-13

Family

ID=19815540

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732311099 Pending DE2311099A1 (de) 1972-03-08 1973-03-06 Psychopharmakologisch aktive peptide und peptidderivate

Country Status (12)

Country Link
JP (1) JPS48103575A (fr)
AU (1) AU471618B2 (fr)
BE (1) BE796478A (fr)
CA (1) CA1025439A (fr)
CH (1) CH584681A5 (fr)
DE (1) DE2311099A1 (fr)
FR (1) FR2181803B1 (fr)
GB (1) GB1425099A (fr)
HU (1) HU169157B (fr)
NL (1) NL7203042A (fr)
SE (1) SE406761B (fr)
ZA (1) ZA731207B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162079A1 (fr) * 1983-11-07 1985-11-27 The Board Of Trustees Of The Leland Stanford Junior University Utilisation des derives d'arg-phe-amide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2560486B1 (fr) * 2010-04-21 2018-11-21 Signature Therapeutics, Inc. Compositions comprenant des promédicaments de type amphétamine clivables par enzyme et leurs inhibiteurs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1301738A (fr) * 1969-07-09 1973-01-04

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162079A1 (fr) * 1983-11-07 1985-11-27 The Board Of Trustees Of The Leland Stanford Junior University Utilisation des derives d'arg-phe-amide
EP0162079A4 (fr) * 1983-11-07 1989-01-19 Univ Leland Stanford Junior Utilisation des derives d'arg-phe-amide.

Also Published As

Publication number Publication date
FR2181803B1 (fr) 1976-09-03
JPS48103575A (fr) 1973-12-25
GB1425099A (en) 1976-02-18
AU471618B2 (en) 1976-04-29
CH584681A5 (fr) 1977-02-15
ZA731207B (en) 1973-11-28
NL7203042A (fr) 1973-09-11
FR2181803A1 (fr) 1973-12-07
CA1025439A (fr) 1978-01-31
AU5251173A (en) 1974-08-22
BE796478A (fr) 1973-09-10
HU169157B (fr) 1976-10-28
SE406761B (sv) 1979-02-26

Similar Documents

Publication Publication Date Title
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DD217807A5 (de) Verfahren zur herstellung neuer substituierter tetrapeptide
DE2649146A1 (de) Nonapeptide
DE2315826A1 (de) Psychopharmakologisch aktive peptide und peptidderivate
DE2308362A1 (de) Psychopharmakologisch aktive peptide und peptidderivate
DE2730549A1 (de) Peptidderivate und deren herstellung
DE2544348A1 (de) L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
CH636598A5 (de) Verfahren zur herstellung neuer psychopharmakologisch aktiver peptide.
DE1493878C3 (de) Acylierte Peptidderivate, Verfahren zur Herstellung derselben und pharmazeutische Präparate, welche solche acylierte Peptidderivate enthalten
DE2335826C2 (de) Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel
CH424797A (de) Verfahren zur Herstellung neuer Oktapeptide mit vasopressorischer Wirksamkeit
DE2731282A1 (de) Psychopharmakologisch wirksame peptide und peptidderivate und verfahren zu deren herstellung
DE2326033C2 (de) Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung
DE1518133B1 (de) Verfahren zur Herstellung eines neuen hypotensiv wirkenden Hendekapeptids
DE2311099A1 (de) Psychopharmakologisch aktive peptide und peptidderivate
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE1248059B (de) Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide
CH658661A5 (de) Peptidverbindungen.
DE2305727C2 (de) Pentapeptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel
DE2649114A1 (de) Octapeptide
DE3236484A1 (de) Tripeptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel
DD296084A5 (de) Verfahren zur herstellung von humanen spleninderivaten
DE2114300C3 (de) Octadekapeptide und Arzneipräparate
DE2559928C2 (de) N-Aroyl-L-phenylalanyl-L-tyrosine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH499497A (de) Verfahren zur Herstellung neuer Polypeptide

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination